Toggle navigation
Home
Pulse
Channels
CME
Profile
Home
Pulse
Channels
CME
Profile
tmodarressi's Talks
@tmodarressi
Advocare Princeton Cardiometabolic Health
Tirzepatide Beats Dulaglutide for Cardiorenal Endpoints
April 27, 2026
@tmodarressi
Advocare Princeton Cardiometabolic Health
Implantable & Ultra-Long-Acting GLP1RA
April 27, 2026
Share
Implantable & Ultra-Long-Acting GLP1RA
https://www.medspoke.co/channel_playlist?object_id=678&tap_id=12442
Copy Link
Email
X
Bluesky
WhatsApp
LinkedIn
Facebook
Reddit
@tmodarressi
Advocare Princeton Cardiometabolic Health
Delay in Statin Therapy in T2D
April 27, 2026
Why are you reporting this TALK?
